303 related articles for article (PubMed ID: 24583027)
1. Treatment of norovirus infections: moving antivirals from the bench to the bedside.
Kaufman SS; Green KY; Korba BE
Antiviral Res; 2014 May; 105():80-91. PubMed ID: 24583027
[TBL] [Abstract][Full Text] [Related]
2. Advances Toward a Norovirus Antiviral: From Classical Inhibitors to Lethal Mutagenesis.
Thorne L; Arias A; Goodfellow I
J Infect Dis; 2016 Feb; 213 Suppl 1(Suppl 1):S27-31. PubMed ID: 26744429
[TBL] [Abstract][Full Text] [Related]
3. Norovirus: targets and tools in antiviral drug discovery.
Rocha-Pereira J; Neyts J; Jochmans D
Biochem Pharmacol; 2014 Sep; 91(1):1-11. PubMed ID: 24893351
[TBL] [Abstract][Full Text] [Related]
4. Progress towards the prevention and treatment of norovirus infections.
Arias A; Emmott E; Vashist S; Goodfellow I
Future Microbiol; 2013 Nov; 8(11):1475-87. PubMed ID: 24199805
[TBL] [Abstract][Full Text] [Related]
5. Norovirus genetic diversity and evolution: implications for antiviral therapy.
Rocha-Pereira J; Van Dycke J; Neyts J
Curr Opin Virol; 2016 Oct; 20():92-98. PubMed ID: 27736665
[TBL] [Abstract][Full Text] [Related]
6. Norovirus gastroenteritis, increased understanding and future antiviral options.
Tan M; Jiang X
Curr Opin Investig Drugs; 2008 Feb; 9(2):146-51. PubMed ID: 18246517
[TBL] [Abstract][Full Text] [Related]
7. Structure(s), function(s), and inhibition of the RNA-dependent RNA polymerase of noroviruses.
Deval J; Jin Z; Chuang YC; Kao CC
Virus Res; 2017 Apr; 234():21-33. PubMed ID: 28041960
[TBL] [Abstract][Full Text] [Related]
8. Post-exposure antiviral treatment of norovirus infections effectively protects against diarrhea and reduces virus shedding in the stool in a mortality mouse model.
Rocha-Pereira J; Kolawole AO; Verbeken E; Wobus CE; Neyts J
Antiviral Res; 2016 Aug; 132():76-84. PubMed ID: 27252124
[TBL] [Abstract][Full Text] [Related]
9. Recent Advances in the Discovery of Norovirus Therapeutics.
Kim Y; Galasiti Kankanamalage AC; Chang KO; Groutas WC
J Med Chem; 2015 Dec; 58(24):9438-50. PubMed ID: 26258852
[TBL] [Abstract][Full Text] [Related]
10. Nitazoxanide Inhibits Human Norovirus Replication and Synergizes with Ribavirin by Activation of Cellular Antiviral Response.
Dang W; Xu L; Ma B; Chen S; Yin Y; Chang KO; Peppelenbosch MP; Pan Q
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30104275
[TBL] [Abstract][Full Text] [Related]
11. Norovirus in health care and implications for the immunocompromised host.
Chong PP; Atmar RL
Curr Opin Infect Dis; 2019 Aug; 32(4):348-355. PubMed ID: 31107251
[TBL] [Abstract][Full Text] [Related]
12. The viral polymerase inhibitor 2'-C-methylcytidine inhibits Norwalk virus replication and protects against norovirus-induced diarrhea and mortality in a mouse model.
Rocha-Pereira J; Jochmans D; Debing Y; Verbeken E; Nascimento MS; Neyts J
J Virol; 2013 Nov; 87(21):11798-805. PubMed ID: 23986582
[TBL] [Abstract][Full Text] [Related]
13. Norovirus antivirals: Where are we now?
Netzler NE; Enosi Tuipulotu D; White PA
Med Res Rev; 2019 May; 39(3):860-886. PubMed ID: 30584800
[TBL] [Abstract][Full Text] [Related]
14. TLR7 Agonists Display Potent Antiviral Effects against Norovirus Infection via Innate Stimulation.
Enosi Tuipulotu D; Netzler NE; Lun JH; Mackenzie JM; White PA
Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29530841
[TBL] [Abstract][Full Text] [Related]
15. Virucidal and Immunostimulating Activities of Monogalactosyl Diacylglyceride from
Hayashi K; Komatsu S; Kuno H; Asai S; Matsuura I; Kudkyal VR; Kawahara T
Mar Drugs; 2022 Feb; 20(2):. PubMed ID: 35200660
[TBL] [Abstract][Full Text] [Related]
16. Antiviral activity of Schizonepeta tenuifolia Briquet against noroviruses via induction of antiviral interferons.
Ng YC; Kim YW; Lee JS; Lee SJ; Jung Song M
J Microbiol; 2018 Sep; 56(9):683-689. PubMed ID: 30141161
[TBL] [Abstract][Full Text] [Related]
17. Anti-norovirus therapeutics: a patent review (2010-2015).
Galasiti Kankanamalage AC; Weerawarna PM; Kim Y; Chang KO; Groutas WC
Expert Opin Ther Pat; 2016; 26(3):297-308. PubMed ID: 26881878
[TBL] [Abstract][Full Text] [Related]
18. Standardization of an antiviral pipeline for human norovirus in human intestinal enteroids demonstrates nitazoxanide has no to weak antiviral activity.
Lewis MA; Cortés-Penfield NW; Ettayebi K; Patil K; Kaur G; Neill FH; Atmar RL; Ramani S; Estes MK
Antimicrob Agents Chemother; 2023 Oct; 67(10):e0063623. PubMed ID: 37787556
[TBL] [Abstract][Full Text] [Related]
19. Advances in norovirus biology.
Karst SM; Wobus CE; Goodfellow IG; Green KY; Virgin HW
Cell Host Microbe; 2014 Jun; 15(6):668-80. PubMed ID: 24922570
[TBL] [Abstract][Full Text] [Related]
20. Current tools for norovirus drug discovery.
Weerasekara S; Prior AM; Hua DH
Expert Opin Drug Discov; 2016 Jun; 11(6):529-41. PubMed ID: 27108716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
